+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

From
From
Multiple Sclerosis Drugs Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Multiple Sclerosis Drugs Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
Protein Inhibitors Market Report 2025 - Product Thumbnail Image

Protein Inhibitors Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Proliferative Diabetic Retinopathy (PDR) Market Report 2025 - Product Thumbnail Image

Proliferative Diabetic Retinopathy (PDR) Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Retinal Vein Occlusion Market Report 2025 - Product Thumbnail Image

Retinal Vein Occlusion Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Age-Related Macular Degeneration Market Report 2025 - Product Thumbnail Image

Age-Related Macular Degeneration Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Alpha Mannosidosis Market Report 2025 - Product Thumbnail Image

Alpha Mannosidosis Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
Loading Indicator